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Abstract
The instability of nonviral vectors in aqueous suspensions has stimulated an interest in developing lyophilized formulations
for use in gene therapy. Previous work has demonstrated a strong correlation between the maintenance of particle size and
retention of transfection rates. Our earlier work has shown that aggregation of nonviral vectors typically occurs during the
freezing step of the lyophilization process, and that high concentrations of sugars are capable of maintaining particle size.
This study extends these observations, and demonstrates that glass formation is not the mechanism by which sugars protect
lipid/DNA complexes during freezing. We also show that polymers (e.g., hydroxyethyl starch) are not capable of preventing
aggregation despite their ability to form glasses at relatively high subzero temperatures. Instead, our data suggest that it is the
separation of individual particles within the unfrozen fraction that prevents aggregation during freezing, i.e., the particle
isolation hypothesis. Furthermore, we suggest that the relatively low surface tension of mono- and disaccharides, as
compared to starch, allows phase-separated particles to remain dispersed within the unfrozen excipient solution, which
preserves particle size and transfection rates during freezing. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
DNA-based therapeutics o¡er promising strategies
for the prevention and treatment of diseases that are
currently considered untreatable [1^3]. Although vi-
ruses have been employed in the majority of gene
therapy clinical trials, the administration of these
agents causes an immune reaction that can limit ther-
apeutic bene¢t and compromise patient health [4^7].
Recently, adverse reactions to viral gene delivery ve-
hicles have been implicated in the deaths of patients
enrolled in clinical trials [8]. These tragic events have
further stimulated an interest in developing e⁄cient
synthetic vectors that do not elicit a speci¢c immune
response. While contemporary nonviral vehicles have
proven to be safe, their e⁄ciency must be improved
if therapeutic levels of heterologous gene expression
are to be realized. Accordingly, nonviral studies to
date have focused almost exclusively on increasing
delivery e⁄ciency, and little attention has been paid
to other critical pharmaceutical aspects, e.g., stabil-
ity.
Contemporary nonviral gene delivery systems typ-
ically employ cationic liposomes or polycations to
collapse DNA via electrostatic interactions [4]. The
resulting complex of DNA with cationic agent has
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been shown to facilitate gene delivery both in vitro
and in vivo [4,9,10]. However, one of the major bar-
riers to the widespread use of these novel pharma-
ceutical agents is their high instability in aqueous
suspensions [11^15]. Early clinical trials circum-
vented this instability by preparing vectors at the
bedside, immediately prior to injection [9,10]. While
more stable nonviral vector preparations have been
developed [16^18], it is doubtful that liquid formula-
tions can be rendered su⁄ciently stable to resist
stresses inherent in shipping and storage [15,19,20].
For example, a freeze-thaw cycle that might be en-
countered during shipping can dramatically reduce
transfection rates [15,19^21]. Previous studies have
demonstrated that high concentrations of sugars
are able to protect nonviral vectors from freezing-
induced damage [16,20^25]. Furthermore, frozen for-
mulations have been shown to retain vector size and
transfection rates during prolonged storage [16,21].
However, the high cost associated with maintaining
the frozen state during shipping and storage is a sig-
ni¢cant drawback [15,19].
In contrast to frozen formulations, dehydrated
preparations are lightweight, and can be shipped
and stored at ambient temperatures. Lyophilization
has proven to be an e¡ective method for the large-
scale production of dried pharmaceuticals. However,
the lyophilization process subjects preparations to
two distinct stresses that are known to damage non-
viral vectors, i.e., freezing and drying [15,19]. Pre-
vious studies on the lyophilization of nonviral vec-
tors have clearly demonstrated that transfection rates
upon rehydration are closely correlated with the
maintenance of particle size [22^26]. These ¢ndings
are consistent with other reports indicating that vec-
tor size plays a critical role in determining rates of
gene delivery [27]. Therefore, the development of
lyophilized formulations requires that particle size
be maintained throughout the lyophilization process.
Although both freezing and drying can promote
aggregation, earlier studies indicate that increases in
particle size are typically manifested during the freez-
ing step of the lyophilization process [20,22,24,25].
Our previous work has shown that the slow cooling
rates achieved during lyophilization cause signi¢-
cantly more aggregation than quick freezing in liquid
nitrogen [20]. Presumably, slow cooling allows com-
plexes su⁄cient time to di¡use away from ice crystals
such that particles are concentrated with excipients in
the unfrozen fraction. As the temperature is further
reduced, the progressive growth of ice crystals causes
vectors to be further concentrated in the unfrozen
fraction, and aggregation is facilitated. The observa-
tion that sugars can be employed to maintain particle
size during freezing indicates that these excipients are
capable of minimizing interactions among individual
particles [15]. However, the mechanism by which ex-
cipients exert this e¡ect on nonviral vectors has yet
to be clearly elucidated.
Earlier work by Levine and Slade [28] has sug-
gested that protection can be achieved by immobiliz-
ing macromolecules in a glassy excipient matrix.
These authors proposed that such a mechanism
could inhibit protein unfolding and aggregation dur-
ing both the freezing and drying steps of lyophiliza-
tion. This hypothesis has become known as the ‘vit-
ri¢cation hypothesis’, and could potentially explain
the observed maintenance of vector size during freez-
ing in the presence of glass-forming carbohydrates
(e.g., sucrose). This hypothesis is consistent with re-
ports by Crowe et al. [29] showing that liposome
fusion can be prevented by vitri¢cation, but that
warming of frozen samples above the glass transition
temperature (TgP) allows fusion to occur. In addition,
these authors show that the physical separation of
dipalmitoylphosphatidylcholine (DPPC) liposomes
within the glassy excipient matrix is su⁄cient to pre-
vent fusion. We propose that a similar physical sep-
aration is responsible for the reported excipient-in-
duced protection of nonviral vectors during freezing.
However, we suggest that particle isolation may be
achieved via an increase in the volume of the unfro-
zen fraction, and therefore vitri¢cation is not re-
quired to maintain particle size.
To test this hypothesis, we employed complexes of
cationic lipid (DMRIE-C) and plasmid DNA as a
model nonviral vector system. Excipients with di¡er-
ent glass-forming tendencies were assessed for their
ability to inhibit aggregation during the freezing step
of a typical lyophilization protocol. In addition, dif-
ferential scanning calorimetry (DSC) was used to
monitor glass formation in di¡erent formulations.
Maintenance of particle size was compared to vitri-
¢cation during freezing to ascertain whether the
physical state of the excipient matrix is the sole de-
terminant of protection. In contrast, our results dem-
BBAMEM 77912 21-9-00
S.D. Allison et al. / Biochimica et Biophysica Acta 1468 (2000) 127^138128
onstrate that sugar/DNA ratios and the volume of
the unfrozen fraction ultimately determine the extent
of cryoprotection.
2. Materials and methods
2.1. Reagents
Sucrose and glucose were purchased from Pfan-
stiehl Laboratories (Waukegan, IL). Mannitol was
purchased from Sigma (St. Louis, MO). Puri¢ed hy-
droxyethyl starch (HES) was obtained from Frese-
nius (Linz, Austria). DMRIE-C is a cationic lipid
formulation consisting of a 1:1 molar ratio of the
cationic lipid DMRIE (1,2-dimyristoyloxypropyl-3-
dimethyl-hydroxy ethyl ammonium bromide) and
cholesterol. DMRIE-C was purchased as an aqueous
suspension (2 mg/ml) from Gibco BRL (Grand Is-
land, NY) and stored at 4‡C. The DNA plasmid
encoding green £uorescent protein (plasmid pGreen
Lantern-1) was obtained from Gibco BRL. DNA
was dissolved in sterile 2.5 mM Tris^HCl pH 8.5
and diluted to a concentration of 1 mg/ml prior to
use.
2.2. Cell culture
African green monkey kidney cells (COS-7: ATCC
No. CRL1651) were obtained from American Type
Culture Collection (Rockville, MD). Cells were incu-
bated at 37‡C in a humidi¢ed atmosphere containing
5% CO2. Cells were maintained in Dulbecco’s modi-
¢ed Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum, 50 U/ml penicillin G, and
50 Wg/ml streptomycin sulfate, and were propagated
by reseeding at 1^3U105 cells/100-mm dish every 2^3
days. For use in our experiments, cultures were
freshly seeded at 5U104 cells/60-mm dish 24 h before
transfection [23].
2.3. Complex preparation and freeze-thawing
protocols
The complexes were prepared with a 3:1 lipid/
DNA weight ratio (50 Wg DMRIE-C/16.7 Wg DNA
in 2.5 mM Tris^HCl pH 8.5) in polypropylene micro-
centrifuge tubes by gentle mixing, and incubated for
30 min at room temperature as previously described
[20]. This method of preparation results in a hetero-
geneous suspension of particles with a calculated
+/3 charge ratio of 0.97. Aliquots of 12 Wl, corre-
sponding to 4 Wg of DNA of the resulting suspension
of lipid/DNA complexes, were diluted to 50 Wl total
with 2.5 mM Tris^HCl, pH 8.5 and mixed with an
equal volume of excipient solutions in Tris bu¡er. To
vary the excipient/DNA ratio, experiments utilized
di¡erent dilutions of complexes and/or altered the
total sample volume (up to 500 Wl). Samples were
then transferred to 1-ml £at-bottomed borosilicate
lyophilization vials (West Co., Litiz, PA). Vials
were placed on the shelf of an FTS Durastop lyo-
philizer (Stone Ridge, NY) and cooled to a shelf
temperature of 340‡C at 2.5‡C/min. Thermocouples
placed in vials consistently indicated sample temper-
atures of 338‡C, presumably due to heat radiating
from the walls of the lyophilization chamber. Sam-
ples were maintained at 338‡C overnight, and rap-
idly thawed in a water bath of 37‡C prior to analysis.
2.4. Transfection assay
Lipid/DNA complexes containing 2 Wg DNA
(thawed and freshly prepared) were diluted in 1 ml
serum-free, antibiotic-free DMEM and applied to a
60-mm dish containing COS-7 cells freshly washed
with phosphate-bu¡ered saline (PBS). This assay re-
quired less lipid and DNA than the dynamic light
scattering experiments, but the concentration of
each component during complex formation was
held constant. The cells were incubated with lipid/
DNA complexes for 4 h before the medium was re-
placed with 3 ml DMEM containing serum and anti-
biotics as described above. The cells were allowed to
grow for approximately 40 h before harvesting. Cells
were harvested and washed as previously described
[20,23]. Cell pellets were washed and resuspended in
PBS for analysis of green £uorescent protein expres-
sion using a Coulter Epics XL £ow cytometer (Hia-
leah, FL). Fluorescence at 525 nm was monitored for
5000 cells per sample, and triplicate transfections
were measured per experimental condition [22].
Under these conditions, fresh complexes consistently
exhibited transfection rates of 30%. Recovery is re-
ported as the percent of cells expressing green £uo-
rescent protein after transfection with thawed com-
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plexes, relative to that obtained with fresh com-
plexes.
2.5. Dynamic light scattering analysis
Triplicate suspensions containing 4 Wg of plasmid,
12 Wg of lipid, and stabilizer were subjected to freeze-
thawing as described above. After rapid thawing,
samples were diluted to 0.5 ml total volume with
distilled water and transferred into a cuvette for dy-
namic light scattering analysis on a Nicomp 370 Sub-
micron Particle Sizer (Particle Sizing Systems, Santa
Barbara, CA). Channel width was set automatically
based on the rate of £uctuation of scattered light
intensity. The data were volume-weighted, and the
analysis assumed that lipid/DNA complexes are solid
particles. For very heterogeneous suspensions with
X2 values greater than 3 (e.g., after freezing at low
excipient/DNA ratios), 106 running sums of intensity
were compiled over 64 channels to ensure that su⁄-
cient data were incorporated into the autocorrelation
function [22].
2.6. DSC
The glass transition temperature of the freeze-con-
centrated excipient solution (TgP) was quanti¢ed with
a Perkin-Elmer DSC-7 di¡erential scanning calorim-
eter (Norwalk, CT). Samples were carefully weighed,
sealed in aluminum pans, and cooled at 2.5‡C/min to
simulate the freezing experiments. During warming
(10‡C/min), TgP was calculated as the midpoint of
the transition in heat capacity as previously described
[30].
2.7. Surface tension measurements
The apparent surface tensions of concentrated so-
lutions of HES, sucrose, and glucose were deter-
mined with a Surface Tensiometer (model 20, Fisher
Scienti¢c). The true surface tension of each solution
was calculated as described by the manufacturer.
Sterile solutions were transferred to 60-mm petri
dishes, and triplicate determinations were made on
each sample. We discovered that a 62.5% HES mix-
ture forms a gel at room temperature, thereby pro-
hibiting the assessment of surface tension at this con-
centration. However, lower concentrations of HES
formed £uid solutions of which the surface tension
could be accurately determined. Thus, measurements
were conducted on a series of HES solutions (10, 20,
30, 40, 50%), and the data extrapolated to a concen-
tration of 62.5%. To insure that thermal equilibrium
had been achieved, all solutions and equipment were
incubated overnight at each temperature (4, 24,
37‡C) prior to the determination of surface tension.
2.8. Statistical analysis
Mean particle sizes of frozen complexes were com-
pared to that of fresh preparations. Statistically sig-
ni¢cant di¡erences were determined using a two-
tailed Student’s t-test with Graphpad Prism Software
(San Diego, CA). Mean particle sizes having P values
less than 0.05 were judged to be signi¢cantly di¡erent
from fresh preparations, and these data points are
indicated in each ¢gure by closed symbols.
3. Results
As shown in previous studies, lipid/DNA com-
plexes form large aggregates during slow freezing
(Fig. 1). Aggregation can be attenuated by the pres-
ence of sucrose, and high excipient concentrations
are capable of maintaining complex sizes comparable
to unfrozen controls (Fig. 1A). However, if a similar
experiment is conducted with a more dilute suspen-
sion of complexes, much lower concentrations of su-
crose are needed to retain complex size (Fig. 1B).
The observation that lower concentrations of com-
plexes require less sucrose for protection indicates
that the initial concentration of excipient is not the
parameter determining maintenance of particle size.
When data from these experiments are plotted
against the sucrose/DNA ratio, it can be seen that
attenuation of aggregation is achieved at ratios
above 500 (Fig. 2). Furthermore, when data from
similar experiments are plotted together, mainte-
nance of particle size is observed in each case at
sucrose/DNA ratios of 1000 (Fig. 2). It is interesting
that the freezing of highly diluted suspensions of
complexes resulted in markedly larger particle sizes
than more concentrated suspensions at the same su-
crose/DNA ratio (Fig. 2). Considering that a greater
mass of ice will be formed in more dilute samples, we
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suspect that increased interactions with the larger ice
crystal surface could potentially explain this e¡ect.
Similar observations with proteins have been attrib-
uted to surface denaturation at the ice^water inter-
face [31]. Regardless of the role of ice crystals in
promoting damage to complexes, particle sizes com-
parable to fresh controls were observed at higher
sucrose/DNA ratios.
As detailed in Section 2, samples in each of the
experiments described above were frozen to 338‡C
and incubated overnight. Since the method of rapid
warming results in practically instantaneous thawing,
it is unlikely that su⁄cient time is available to allow
aggregation during warming. Instead, our results
suggest that aggregate formation occurred during
the freezing process. We point out that frozen su-
crose forms a glass at 332‡C (Table 1) that immo-
bilizes complexes, and could potentially explain the
observed maintenance of particle size. However, even
samples with low sucrose/DNA ratios that do not
prevent aggregation are glassy under our experimen-
Fig. 1. E¡ect of sucrose concentration on the maintenance of
particle size during freezing. DNA concentrations of 160 Wg/ml
(A) and 40 Wg/ml (B) were employed in separate sets of samples
subjected to freezing. The horizontal line at approximately 350
nm represents the size of complexes prior to freezing. Particle
diameters that were signi¢cantly di¡erent (P6 0.05) from unfro-
zen controls are indicated by closed symbols. Each symbol rep-
resents the mean þ 1 S.D. of single measurements on triplicate
samples.
Fig. 2. E¡ect of sucrose/DNA weight ratio on the retention of
particle size during freezing. Particle diameters of four di¡erent
series of samples with constant DNA concentrations of 8 Wg/ml
(diamonds), 40 Wg/ml (circles), and 160 Wg/ml (squares) or con-
stant sucrose concentration (1%, triangles) were assessed after
freeze-thawing. The horizontal line at approximately 350 nm
represents the size of complexes prior to freezing. Particle diam-
eters that were signi¢cantly di¡erent (P6 0.05) from unfrozen
controls are indicated by closed symbols. Each symbol repre-
sents the mean þ 1 S.D. of single measurements on triplicate
samples.
Table 1
Glass transition temperatures of di¡erent samples
Excipient Excipient/DNA (w/w) TgP (‡C)a
HES 300 310.9 þ 02
HES 600 310.2 þ 0.2
HES r 39.4 þ 0.7
Sucrose 60 337.2 þ 0.2
Sucrose 300 332.4 þ 0.7
Sucrose 600 331.6 þ 0.2
Sucrose r 331.3 þ 0.5
Glucose 60 347.2 þ 0.3
Glucose 300 344.0 þ 0.4
Glucose 600 343.1 þ 0.2
Glucose r 342.6 þ 0.2
aValues represent the mean þ 1 S.D. of single calorimetric scans
on triplicate samples.
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tal conditions (compare Table 1 and Fig. 2). These
data indicate that formation of a glassy state is not
the mechanism by which sucrose prevents aggrega-
tion during freezing.
Similar protection was observed when glucose was
used as a stabilizing excipient (Fig. 3). Again, particle
sizes comparable to unfrozen controls were achieved
at sugar/DNA ratios above 500. In contrast to the
sucrose samples, complexes suspended in glucose did
not vitrify under our conditions, and therefore im-
mobilization of particles in a glassy matrix cannot
explain the observed protection (Table 1). Consistent
with this assertion, samples containing HES
(TgP=310‡C) vitri¢ed at high subzero temperatures,
yet particle size was not retained even at the highest
concentrations investigated (Fig. 4). While an in-
crease in HES/DNA ratio did attenuate aggregation
to some degree, the ability of HES to maintain vec-
tor size was clearly inferior to that observed with
sucrose and glucose (compare Fig. 4 with Figs. 2
and 3). Analysis of the calorimetric data shows that
frozen mixtures of complexes and HES exhibited two
distinct glass transitions, suggesting that the physical
properties of these two components are not coupled
(Fig. 5). This is not surprising considering that com-
plexes form a suspension, and are therefore phase-
separated from the excipient solution. It is worth
noting that the presence of complexes clearly alters
the TgP of each of the excipients (Table 1). These
¢ndings indicate that although particles in suspen-
sion are phase-separated from the excipients, inter-
actions with suspended complexes do in£uence the
Fig. 3. E¡ect of glucose/DNA weight ratio on the retention of
particle size during freezing. A constant concentration of glu-
cose (1%, triangles) or DNA (40 Wg/ml, circles) was employed
in separate sets of samples subjected to freezing. The horizontal
line at approximately 350 nm represents the size of complexes
prior to freezing. Particle diameters that were signi¢cantly dif-
ferent (P6 0.05) from unfrozen controls are indicated by closed
symbols. Each symbol represents the mean þ 1 S.D. of single
measurements on triplicate samples.
Fig. 4. E¡ect of HES/DNA weight ratio on the retention of
particle size during freezing. A constant concentration of HES
(1%, triangles) or DNA (40 Wg/ml, circles) was employed in sep-
arate sets of samples subjected to freezing. The horizontal line
at approximately 350 nm represents the size of complexes prior
to freezing. The closed symbols at each ratio indicate that par-
ticle diameters were signi¢cantly di¡erent (P6 0.05) from unfro-
zen controls in every case. Each symbol represents the mean þ 1
S.D. of single measurements on triplicate samples.
Fig. 5. DSC indicates that lipid/DNA complexes remain sepa-
rated from the excipient solution. DSC thermogram shows the
di¡erent glass transitions (arrows) in a frozen mixture of
DMRIE-C/DNA complexes and HES. Vertical bar equals 0.1
W/g.
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physical properties of the excipient solution. There-
fore, it is possible that the characteristics of the ex-
cipient may impact the stability of the suspended
complexes.
Similar to protection by HES, increasing concen-
trations of mannitol helped maintain complex size,
but diameters comparable to fresh samples were not
recovered even at the highest mannitol/DNA ratios
(Fig. 6). The fact that mannitol does not fully pre-
serve complex size is consistent with our observation
that it crystallizes during freezing [22,32]. However,
these data show that mannitol does o¡er signi¢cant
levels of protection (Fig. 6). We suggest that eutectic
crystallization of mannitol during freezing may be
capable of spatially separating complexes and attenu-
ating particle interactions.
Another factor that may limit the dispersion of
complexes within excipient solutions is surface ten-
sion. Considering that the surface tension of aqueous
solutions progressively increases with greater exci-
pient concentrations and lower temperatures, an ex-
cipient solution possessing high surface tension could
potentially reduce energetically unfavorable surface
area by expelling phase-separated particles. Accord-
ingly, the rejection of particles from the excipient
solution could cause complexes to coalesce and ag-
gregate during freezing. Of course, this argument is
not valid if the solution has vitri¢ed. But, prior to
glass formation, surface tension may partially deter-
mine whether complexes remain dispersed (isolated)
in the unfrozen fraction. To investigate the potential
role of surface tension, we ¢rst utilized DSC mea-
surements to calculate the excipient concentrations
in the unfrozen fraction. By analyzing the enthalpy
of melting, we calculated the amount of water that
Fig. 6. E¡ect of mannitol/DNA weight ratio on the retention of
particle size during freezing. A constant concentration of man-
nitol (1%, triangles) or DNA (40 Wg/ml, circles) was employed
in separate sets of samples subjected to freezing. The horizontal
line at approximately 350 nm represents the size of complexes
prior to freezing. The closed symbols at each ratio indicate that
particle diameters were signi¢cantly di¡erent (P6 0.05) from
unfrozen controls in every case. Each symbol represents the
mean þ 1 S.D. of single measurements on triplicate samples.
Fig. 7. E¡ect of excipients on surface tension in the unfrozen
fraction. The surface tension of concentrated excipient solutions
was assessed at 4‡C, 24‡C, and 37‡C. Di¡erent HES concentra-
tions (10^50%) are plotted with ¢tted regression lines (A). The
regression analysis was used to extrapolate the surface tension
of 62.5% HES at each temperature. The surface tensions of ex-
cipient solutions at their respective concentrations in the unfro-
zen fraction are plotted with regression lines extrapolating to
subzero temperatures. Vertical lines indicate the sample temper-
ature (338‡C) and measured TgP values for sucrose (332‡C)
and HES (310‡C). Each symbol represents the mean of tripli-
cate measurements on a single solution. Standard deviations are
within the size of the symbols.
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remained unfrozen in di¡erent samples at 338‡C.
Our results indicate that HES, sucrose, and glucose
have concentrations of 62.5%, 58% and 45.5% (w/w),
respectively, in their unfrozen fractions. Thus, we
measured the surface tension of these solutions at
di¡erent temperatures and extrapolated these data
to subzero temperatures. Our data show the surface
tensions of HES solutions are markedly higher at
low temperatures than comparable solutions of either
glucose or sucrose (Fig. 7). However, if our measure-
ments are extrapolated to temperatures at which
complexes would have experienced a £uid (non-
glassy) environment (i.e., 310‡C, 332‡C, 338‡C
for HES, sucrose, and glucose, respectively), the sur-
face tension of unfrozen HES is comparable to that
of sucrose or glucose. It should be noted that the
extrapolation of surface tension measurements to
subzero temperatures may not be linear as depicted
in Fig. 7. Unfortunately, technical di⁄culties in-
volved in determining the surface tension of partially
frozen solutions prevent us from directly testing the
accuracy of our extrapolation.
Additional experiments were performed to deter-
mine if the maintenance of particle size during freez-
ing was su⁄cient to preserve transfection rates. For
each additive investigated here, transfection rates
were assessed after freeze-thawing at low and high
excipient/DNA ratios (Fig. 8). Consistent with that
observed for the retention of particle size, low exci-
pient/DNA ratios resulted in signi¢cant reductions in
transfection rates. At high excipient levels, only su-
crose and glucose were capable of maintaining trans-
fection levels comparable to fresh preparations (Fig.
8). Surprisingly, high mannitol levels o¡ered signi¢-
cantly more protection than HES, again suggesting
that mechanisms other than the formation of a glassy
matrix contribute to the observed preservation of
complexes during the freezing step of lyophilization.
4. Discussion
The data in Fig. 1 are consistent with previous
reports showing that sucrose is capable of maintain-
ing complex sizes during freezing [20,22,24,25]. In
addition, our observations demonstrate that the ini-
tial sucrose concentration (i.e., prior to freezing) at
which protection is observed is altered dramatically if
more dilute suspensions of complexes are employed.
These ¢ndings demonstrate that it is not the initial
sucrose concentration that determines the level of
protection during freezing. Instead, the amount of
sucrose relative to the quantity of complexes (i.e.,
sucrose/DNA ratio) appears to dictate preservation
of particle size (Fig. 2). Previous studies have sug-
gested that immobilization in a glassy excipient ma-
trix is su⁄cient to prevent aggregation [28,29,33].
According to this suggestion, formation of a glass
should be su⁄cient to preserve particle size. To the
contrary, our data demonstrate that vitri¢cation oc-
curs at sucrose/DNA ratios well below that at which
protection is observed (Table 1). Furthermore, HES,
which readily vitri¢ed during freezing, was not able
to maintain particle size (Fig. 4). Moreover, glucose
e¡ectively preserved particle sizes despite the lack of
glass formation under our conditions (Fig. 3).
Although these ¢ndings do not completely rule out
vitri¢cation as a contributing factor in cryoprotec-
tion, our results are clearly incompatible with glass
formation as the major determinant of particle size
retention. Consistent with the e¡ects on complex size
after freezing, only sucrose and glucose were capable
of maintaining transfection rates comparable to fresh
preparations (Fig. 8).
To investigate the e¡ect of excipients that crystal-
lize during freezing, complexes were suspended in so-
lutions of mannitol (Fig. 6). Surprisingly, increasing
mannitol/DNA ratios dramatically inhibited aggrega-
tion, even though eutectic crystallization was clearly
Fig. 8. Transfection rates after freezing at high and low exci-
pient/DNA ratios. Transfection rates of complexes frozen at ex-
cipient/DNA ratios of 12.5 (closed bars) and 625 (open bars)
were assessed after freezing. Each bar indicates the mean þ 1
S.D. of transfection rates in triplicate cell dishes.
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evident (data not shown). In fact, protection by man-
nitol was very similar to that observed with HES
despite the distinct di¡erences in the physical state
of these two excipients, i.e., crystalline vs. glassy
(compare Figs. 4 and 6). It is possible that a very
small amount of mannitol (undetectable by DSC)
remains associated with the complexes and attenu-
ates aggregation by sterically inhibiting interactions
between particles. However, we would expect that
any association with complexes would be saturated
at mannitol concentrations that crystallize. Our data
show that increasing levels of mannitol progressively
inhibit aggregation despite crystallization at low
mannitol/DNA ratios during freezing (Fig. 6). There-
fore, we feel it is unlikely that a direct association of
mannitol with the complexes is responsible for the
observed attenuation of aggregation.
The inability of glass-forming excipients to pre-
serve macromolecular integrity is well known
[34,35]. Crowe et al. [29,33^36] have long argued
that vitri¢cation is insu⁄cient to preserve macromo-
lecules during freeze-drying. These authors have pro-
posed that sugars hydrogen bond directly to dehy-
drated lipids, and prevent membrane phase
transitions that cause leakage of encapsulated solutes
during lyophilization [34,35]. However, their work
has also shown that stabilization of liposomes with
high phase transition temperatures (e.g., DPPC) re-
quires only that aggregation and fusion be prevented
[29]. During freezing, this can be accomplished by
excipients that form glasses, e.g., dextran. To illus-
trate this e¡ect, Crowe et al. [29] demonstrated that
frozen DPPC liposomes readily aggregate and fuse
when incubated at temperatures above TgP.
In contrast to our experiments, the reports de-
scribed above utilized traditional liposomes, and
are therefore not directly comparable. Although the
physical properties of lipid/DNA complexes have yet
to be fully characterized [37], these particles are too
large to be dissolved in solution. Thus, like lipo-
somes, lipid/DNA complexes form a suspension
that remains phase-separated from the aqueous exci-
pient solution (Fig. 5). Furthermore, the electrostatic
interactions between cationic lipids and DNA are
su⁄ciently strong to prevent dissociation (i.e., ‘leak-
age’) during lipid phase transitions. However, the
particles in our study contain lipids that can sponta-
neously aggregate and fuse with other complexes if
physical contact is achieved. Therefore, we feel it is
reasonable to compare our data on the maintenance
of complex size to results by Crowe et al. that uti-
lized DPPC liposomes [29]. Regardless of the validity
of this comparison, our ¢ndings are not consistent
with the suggestion that vitri¢cation is su⁄cient to
prevent aggregation of suspended particles during
freezing [28,29]. Instead, our data indicate that vitri-
¢cation, alone, does not fully preserve particle size
(Fig. 4). Furthermore, incubation of complexes fro-
zen in glucose above TgP is su⁄cient to prevent ag-
gregation over the time course of our experiments
(V18 h).
In an e¡ort to explain the lack of aggregation ob-
served in our experiments with glucose, it seems pos-
sible that the mobility of complexes is su⁄ciently
retarded to prevent interactions between particles
over the duration of our experiments. Although glu-
cose was not vitri¢ed under our experimental condi-
tions, the viscous unfrozen fraction at 338‡C may
su⁄ciently slow the di¡usion of complexes to prevent
aggregation. According to this hypothesis, the time
complexes spend in the freeze-concentrated state
plays a critical role in determining the extent of ag-
gregation. Obviously, any non-zero rate of di¡usion
will permit aggregation given su⁄cient time. For the
purposes of our studies, we chose a timeframe con-
sistent with primary drying in a typical lyophilization
protocol.
It is important to note that suspended particles
should not signi¢cantly alter the freezing point of
the excipient solution. Accordingly, the concentra-
tion of glucose in the unfrozen fraction is determined
solely by the sample temperature regardless of the
initial sugar concentration prior to freezing. Thus,
the glucose concentrations at 338‡C are equivalent
for every data point shown in Fig. 3. If we assume
that phase-separated particles have little e¡ect on the
physical properties of the unfrozen excipient solution
(especially at the high sugar/DNA ratios employed
here), the viscosity in each of these glucose samples
should also be comparable. As mentioned above, the
high viscosity of the unfrozen fraction may serve to
immobilize complexes and prevent aggregation.
While our experiments did not monitor viscosity dur-
ing freezing, complete protection was only observed
at high glucose/DNA ratios (Fig. 3), indicating that
viscosity, alone, cannot explain our ¢ndings.
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In addition to incubation time and viscosity, the
average distance separating complexes in the unfro-
zen fraction will also determine whether particles can
physically interact. Thus, a more concentrated sus-
pension of complexes in the unfrozen solution will
have a greater probability of aggregation. Although
the glucose concentration at 338‡C is the same in all
cases, the volume of the unfrozen fraction is directly
dependent on the initial glucose concentration prior
to freezing. It follows that the concentration of com-
plexes in the unfrozen fraction is determined by the
glucose/DNA ratio used in sample preparation, i.e.,
higher ratios result in lower concentrations of sus-
pended particles in the unfrozen fraction. This is
consistent with the progressive inhibition of aggrega-
tion observed at higher glucose/DNA ratios (Fig. 3).
Considering the di¡erent factors discussed above,
our data are most consistent with the suggestion that
aggregation during freezing is prevented at high glu-
cose/DNA ratios by isolating complexes within a vis-
cous unfrozen syrup. The same mechanism could
apply during freezing in the presence of other exci-
pients that have TgP values below the sample temper-
ature during primary drying. Although complexes in
sucrose are immobilized in a glass at 338‡C, we
presume that particle isolation is responsible for the
maintenance of complex size during freezing above
TgP. Furthermore, we suggest that a similar mecha-
nism could potentially explain the partial protection
by mannitol, provided that crystalline material could
serve to spatially isolate particles (Fig. 6). This is
consistent with our previous work with mannitol,
and the general observation that other excipients
which crystallize during lyophilization (e.g., polyeth-
ylene glycol) also o¡er partial protection to lipid/
DNA complexes [22]. However, we have yet to ob-
serve complete maintenance of complex size in for-
mulations that do not remain amorphous.
The inability of HES to preserve complex size dur-
ing freezing is puzzling. As shown in Table 1, HES
has a high TgP (V310‡C) consistent with earlier re-
ports [32]. It would seem that complexes dissolved in
HES would be separated in a viscous, starchy solu-
tion similar to that proposed for sugars. Once the
sample temperatures decreased below TgP, complexes
would be immobilized in a glass, and could not ag-
gregate. However, it is possible that the freeze-in-
duced concentration of HES involves a process by
which complexes are expelled from the viscous
HES solution. We propose that this process does
not allow individual complexes to remain fully dis-
persed in the unfrozen HES solution, in contrast to
the mechanism proposed for protection by glucose
and sucrose.
Complexes suspended in a solution represent an
emulsion of which the stability is governed by the
surface tension of the dispersion medium, i.e., the
excipient solution [38]. Therefore, complexes will
tend to coalesce in response to a high surface tension,
whereas a low surface tension will allow particles to
remain dispersed in the excipient solution. This e¡ect
is enhanced during cooling because the surface ten-
sion of aqueous solutions is greater at lower temper-
atures. Furthermore, the surface tension is abruptly
increased upon ice nucleation due to the instantane-
ous rise in excipient concentration. In order to ex-
plain the inability of HES to fully preserve particle
size, the HES solution in the unfrozen fraction would
have to possess a signi¢cantly higher surface tension
than that of sucrose and glucose. Our measurements
are consistent with this hypothesis and demonstrate a
markedly higher surface tension in HES solutions
that simulate the unfrozen fraction (Fig. 7). Based
on these results, we suggest that the high surface
tension of HES solutions might cause suspended
complexes to coalesce during freezing, resulting in
the observed aggregation. Conversely, the relatively
low surface tensions of concentrated sucrose and glu-
cose solutions may allow complexes to remain dis-
persed in the sugar solution, thereby isolating indi-
vidual particles and preventing aggregation during
freezing.
While the surface tension argument presented
above is compelling, it should be pointed out that
viscosity increases many orders of magnitude and
translational motion is greatly retarded upon glass
formation [32]. As a result, aggregation cannot occur
after vitri¢cation. Thus, it could be argued that the
relevant surface tension is that exhibited by the so-
lution just prior to vitri¢cation, i.e., at TgP. If we take
into account the temperature di¡erence between glass
formation in sucrose and HES (i.e., 332‡C vs.
310‡C), our extrapolated data indicate that surface
tensions would be approximately equivalent in these
solutions (Fig. 7). However, the higher viscosity at
lower temperatures would also contribute toward
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particle isolation, and therefore additional studies
would be required to fully address this question. In
addition, the observation that 62.5% HES forms a
gel might indicate that a gelation process that occurs
during freezing could also contribute to our observa-
tions (see Section 2).
In conclusion, our data show that sucrose and
glucose e¡ectively prevent aggregation of lipid/
DNA complexes during the freezing step of the ly-
ophilization process. We propose that these sugars
isolate individual particles in the unfrozen fraction,
thereby preventing aggregation during freezing, i.e.,
the particle isolation hypothesis. We point out that
vitri¢cation is not required for this e¡ect, and suggest
that spatial separation of particles within the unfro-
zen fraction is su⁄cient to prevent aggregation. Ac-
cording to this hypothesis, su⁄cient quantities of
virtually any excipient should o¡er similar protection
during freezing, a supposition that is consistent with
our previous ¢ndings [20,22,23]. Furthermore, the
high excipient/DNA ratios required for protection
indicate that the concentrated nonviral vector sus-
pensions employed in clinical trials may be di⁄cult
to preserve by lyophilization. For example, a sugar/
DNA ratio of 1000 (as required for consistent pro-
tection in this study) would be physically impossible
to achieve at a DNA concentration of 1 mg/ml. Sim-
ilarly, an isotonic sucrose solution would only be
su⁄cient to protect a vector preparation with a
DNA concentration of 0.1 mg/ml. Of course, hyper-
tonic sugar solutions could be employed to improve
protection during lyophilization, but this approach
would signi¢cantly lengthen primary drying times
and increase production costs. Therefore, we suggest
that combinations of excipients with optimized phys-
ical properties might be engineered for more e⁄cient
cryoprotection. We also point out that the conditions
needed to preserve the DMRIE-C/DNA complexes
employed in this study may not be generally appli-
cable to other nonviral vectors. It is possible that
vectors that incorporate di¡erent cationic compo-
nents (e.g., polyethylene imine) and/or polyethylene
glycol may be more resistant to freezing-induced ag-
gregation. Therefore, other vectors might prove to be
more amenable to lyophilization at high DNA con-
centrations. Future experiments are designed to in-
vestigate the applicability of our ¢ndings to the ly-
ophilization of other nonviral vectors.
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